Hepatitis B: The view from West Africa

Mario Lepore; Harr F. Njai; Deborah A. Garside; Yusuke Shimakawa; Mary M.E. Crossey; Ramou Njie; Maud Lemoine

South Sudan Medical Journal (May 2015)

Hepatitis B: The view from West Africa

Mario Lepore,
Harr F. Njai,
Deborah A. Garside,
Yusuke Shimakawa,
Mary M.E. Crossey,
Ramou Njie,
Maud Lemoine

Affiliations

Mario Lepore: Department of Medicine, Imperial College London, St Mary’s Campus
Harr F. Njai: Medical Research Council, The Gambia Unit
Deborah A. Garside: Department of Medicine, Imperial College London, St Mary’s Campus
Yusuke Shimakawa: Department of Medicine, Imperial College London, St Mary’s Campus
Mary M.E. Crossey: Department of Medicine, Imperial College London, St Mary’s Campus
Ramou Njie: Department of Medicine, Imperial College London, St Mary’s Campus
Maud Lemoine: Medical Research Council, The Gambia Unit

Journal volume & issue: Vol. 8, no. 2
pp. 33 – 35

Abstract

Read online

The Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study began in 2011 in The Gambia, Sénégal and Nigeria. The study aims to reduce the risk of hepatocellular carcinoma (HCC) in West Africa through the suppression of the Hepatitis B virus (HBV). The biological samples collected allow for the detection of novel liver cancer biomarkers in the hope of improving the diagnostic ability of early disease states. The PROLIFICA platform hopes to improve cancer diagnostics whilst simultaneously providing the training, skills and infrastructure necessary to develop the quality of liver cancer care in West Africa.

Published in South Sudan Medical Journal

ISSN: 2309-4605 (Print); 2309-4613 (Online)
Publisher: Health and Social Sciences Research Institute - South Sudan (HSSRI-SS)
Country of publisher: South Sudan
LCC subjects: Medicine: Public aspects of medicine
Website: http://www.southsudanmedicaljournal.com

About the journal